Abbott Laboratories (ABT)
104.68
-0.26
(-0.25%)
USD |
NYSE |
May 09, 16:00
104.82
+0.14
(+0.13%)
After-Hours: 20:00
Abbott Laboratories Price to Book Value: 4.692 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 4.704 |
| May 07, 2024 | 4.759 |
| May 06, 2024 | 4.735 |
| May 03, 2024 | 4.747 |
| May 02, 2024 | 4.748 |
| May 01, 2024 | 4.764 |
| April 30, 2024 | 4.75 |
| April 29, 2024 | 4.808 |
| April 26, 2024 | 4.82 |
| April 25, 2024 | 4.790 |
| April 24, 2024 | 4.791 |
| April 23, 2024 | 4.823 |
| April 22, 2024 | 4.799 |
| April 19, 2024 | 4.809 |
| April 18, 2024 | 4.719 |
| April 17, 2024 | 4.747 |
| April 16, 2024 | 4.895 |
| April 15, 2024 | 4.881 |
| April 12, 2024 | 4.891 |
| April 11, 2024 | 4.996 |
| April 10, 2024 | 4.983 |
| April 09, 2024 | 5.040 |
| April 08, 2024 | 4.954 |
| April 05, 2024 | 4.984 |
| April 04, 2024 | 4.936 |
| Date | Value |
|---|---|
| April 03, 2024 | 4.988 |
| April 02, 2024 | 5.021 |
| April 01, 2024 | 5.024 |
| March 31, 2024 | |
| March 28, 2024 | 5.109 |
| March 27, 2024 | 5.101 |
| March 26, 2024 | 5.012 |
| March 25, 2024 | 4.945 |
| March 22, 2024 | 4.970 |
| March 21, 2024 | 5.012 |
| March 20, 2024 | 5.012 |
| March 19, 2024 | 5.086 |
| March 18, 2024 | 5.054 |
| March 15, 2024 | 5.191 |
| March 14, 2024 | 5.342 |
| March 13, 2024 | 5.401 |
| March 12, 2024 | 5.428 |
| March 11, 2024 | 5.402 |
| March 08, 2024 | 5.437 |
| March 07, 2024 | 5.435 |
| March 06, 2024 | 5.364 |
| March 05, 2024 | 5.326 |
| March 04, 2024 | 5.396 |
| March 01, 2024 | 5.332 |
| February 29, 2024 | 5.333 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.563
Minimum
Mar 23 2020
7.267
Maximum
Dec 27 2021
5.414
Average
5.237
Median
Jan 31 2023
Price to Book Value Benchmarks
| Stryker Corp | 6.573 |
| Boston Scientific Corp | 5.468 |
| Insulet Corp | 16.97 |
| Intuitive Surgical Inc | 9.798 |
| Edwards Lifesciences Corp | 7.400 |
Price to Book Value Related Metrics
| PE Ratio | 32.61 |
| PS Ratio | 4.539 |
| Price to Free Cash Flow | 37.18 |
| Price | 104.68 |
| Earnings Yield | 3.07% |
| Market Cap | 182.10B |
| Operating PE Ratio | 28.80 |
| Normalized PE Ratio | 32.44 |